Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Incyte Corporation
M.D. Anderson Cancer Center
ARCAGY/ GINECO GROUP
Xencor, Inc.
National Cancer Institute (NCI)
Incyte Corporation